Aldeyra Therapeutics Inc. buy BiotechBee
Start price
01.10.23
/
70%
€6.42
Target price
30.11.25
€10.00
Performance (%)
-73.55%
End price
16.10.23
€1.70
Summary
This prediction ended on 16.10.23 with a price of €1.70. The BUY prediction by BiotechBee for Aldeyra Therapeutics Inc. performed very badly with a performance of -73.55%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Aldeyra Therapeutics Inc. | 6.685% | 6.685% | -8.795% |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% |
According to BiotechBee what are the pros and cons of Aldeyra Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Aldeyra Therapeutics Inc. diskutieren
Buy mit Kursziel 10,0